1 Zhang S, "miR-98 regulates cisplatininduced A549 cell death by inhibiting TP53 pathway" 65 : 436-442, 2011
2 Baade P, "Trends in melanoma mortality in Australia : 1950–2002and their implications for melanoma control" 29 : 383-386, 2005
3 Coory M, "Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002" 17 : 21-27, 2006
4 Naugler WE, "The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer" 14 : 109-119, 2008
5 Jostock T, "Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses" 268 : 160-167, 2001
6 Hoejberg L, "Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma" 22 : 287-293, 2012
7 Bar-Eli M, "Searching for the ‘melano-miRs’ : miR-214 drives melanoma metastasis" 30 : 1880-1881, 2011
8 Mueller DW, "Role of miRNAs in the progression of malignant melanoma" 101 : 551-556, 2009
9 Schuchter LM, "Review of the 2001 AJCC staging system for cutaneous malignant melanoma" 3 : 332-337, 2001
10 Karst AM, "Nuclear factor kappa B subunit p50promotes melanoma angiogeensis by upregulating interleukin 6 expression" 124 : 494-507, 2009
1 Zhang S, "miR-98 regulates cisplatininduced A549 cell death by inhibiting TP53 pathway" 65 : 436-442, 2011
2 Baade P, "Trends in melanoma mortality in Australia : 1950–2002and their implications for melanoma control" 29 : 383-386, 2005
3 Coory M, "Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002" 17 : 21-27, 2006
4 Naugler WE, "The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer" 14 : 109-119, 2008
5 Jostock T, "Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses" 268 : 160-167, 2001
6 Hoejberg L, "Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma" 22 : 287-293, 2012
7 Bar-Eli M, "Searching for the ‘melano-miRs’ : miR-214 drives melanoma metastasis" 30 : 1880-1881, 2011
8 Mueller DW, "Role of miRNAs in the progression of malignant melanoma" 101 : 551-556, 2009
9 Schuchter LM, "Review of the 2001 AJCC staging system for cutaneous malignant melanoma" 3 : 332-337, 2001
10 Karst AM, "Nuclear factor kappa B subunit p50promotes melanoma angiogeensis by upregulating interleukin 6 expression" 124 : 494-507, 2009
11 Zhang L, "MicroRNAs exhibit high frequency genomic alterations in human cancer" 103 : 9136-9141, 2006
12 Xiang Q, "MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2" 68 : 274-281, 2013
13 Huang SD, "MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma" 11 : 51-, 2012
14 Bemis LT, "MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines" 68 : 1362-1368, 2008
15 Siragam V, "MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11" 3 : 1370-1385, 2012
16 Schultz J, "MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth" 18 : 549-557, 2008
17 Howell PM, "MicroRNA in melanoma" 10 : 83-92, 2010
18 Lu J, "MicroRNA expression profiles classify human cancers" 435 : 834-838, 2005
19 Mueller DW, "MiRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma" 129 : 1740-1751, 2009
20 Tucker MA, "Melanoma epidemiology" 23 : 383-395, 2009
21 Fu TY, "Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells" 317 : 445-451, 2011
22 Hoejberg L, "Interleukin-6 and melanoma" 22 : 327-333, 2012
23 Terai M, "Interleukin 6 mediates production of interleukin 10 in metastatic melanoma" 61 : 145-155, 2012
24 Linos E, "Increasing burden of melanoma in the United States" 129 : 1666-1674, 2009
25 Ting HJ, "Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D" 288 : 1-9, 2013
26 Panda H, "Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3" 97 : E1316-E1326, 2012
27 Jemal A, "Cancer statistics, 2008" 58 : 71-96, 2008
28 Segura MF, "Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor" 106 : 1814-1819, 2009